Back to Catalog

Gastric Cancer Models

Co-clinical study demonstrated 66.79% drug response prediction accuracy across 7 patients and 5 drugs.

PDO 1.0 & 2.0

H&E, IHC, NGS

Validated Applications:

Co-clinical prospective drug response prediction
Standard-of-care chemotherapy evaluation

Clinical Correlation:

66.79% accuracy across 7 patients and 5 drugs (prospective co-clinical)

Read the Gastric Cancer Case Study Request Gastric Models